Medicines Formulary

Medicines A–Z

R

Drug name	NICE TAs	Comments
Rivastigmine patches	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Rizatriptan tablets		Reserved for patients who are vomiting due to migraine
Rocuronium injection
Roflumilast (Daxas)	TA461 - Roflumilast for treating chronic obstructive pulmonary disease	To be use in line with NICE. Supported with a RICaD
Romiplostim injection	TA221 - Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura
Romosozumab (Evenity®)	TA791 - Romosozumab for treating severe osteoporosis
Ropinirole M/R tablets		ESCA for Parkinson's disease
Ropinirole tablets		ESCA for restless legs
Ropivacaine 75mg/10ml injection
Rosuvastatin tablets		40mg dose can be titrated up to on specialist recommendation for patient safety reasons as per the Summary Product Characteristics.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.